PALYNZIQ

Serial Number 87516640
Registration 5576853
702

Registration Progress

Application Filed
Jul 5, 2017
Under Examination
Jan 2, 2018
Approved for Publication
Nov 7, 2017
Published for Opposition
Nov 7, 2017
Registered
Oct 2, 2018

Trademark Image

PALYNZIQ

Basic Information

Serial Number
87516640
Registration Number
5576853
Filing Date
July 5, 2017
Registration Date
October 2, 2018
Published for Opposition
November 7, 2017
Drawing Code
5

Status Summary

Current Status
Active
Status Code
702
Status Date
Dec 31, 2024
Registration
Registered
Classes
005

Rights Holder

Biomarin Pharmaceutical Inc.

03
Address
105 Digital Drive
Novato, CA 94949

Ownership History

Biomarin Pharmaceutical Inc.

Original Applicant
03
Novato, CA

Biomarin Pharmaceutical Inc.

Owner at Publication
03
Novato, CA

Biomarin Pharmaceutical Inc.

Original Registrant
03
Novato, CA

Legal Representation

Attorney
Gregory J. Chinlund

USPTO Deadlines

Next Deadline
1156 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-10-02)
Due Date
October 02, 2028
Grace Period Ends
April 02, 2029

Application History

29 events
Date Code Type Description Documents
Dec 31, 2024 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Dec 31, 2024 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Dec 30, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jul 30, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Oct 2, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Dec 9, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 9, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Dec 9, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 9, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 2, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 29, 2018 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 28, 2018 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 21, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 20, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 23, 2018 IUAF S USE AMENDMENT FILED Loading...
Jul 23, 2018 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 30, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 28, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 28, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 28, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 28, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 2, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 7, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 7, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 18, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 28, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 28, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 12, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 8, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for use in enzyme therapy
First Use Anywhere: Jul 2, 2018
First Use in Commerce: Jul 2, 2018

Additional Information

Design Mark
The mark consists of an upper-case of letter "P" and the lower-case letters of "alynziq".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005